When it comes to oncology clinical trials, drug developers
need to stay abreast of the rapidly evolving and competitive landscape while also remaining flexible and innovative in responding to these changes
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.